Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DNL.L (DNL) Regulatory News

Date Source Headline
14th Nov 2018 11:38 am RNS Results of Annual General Meeting
14th Nov 2018 10:16 am RNS Issue of Equity and Exercise of Options
18th Oct 2018 7:15 am EQS Hardman & Co Research: Diurnal Group (DNL): Unexpected Phase III trial outcome
17th Oct 2018 7:00 am RNS Update on late-stage development pipeline
8th Oct 2018 4:00 pm RNS Posting of Annual Report and AGM Notice
8th Oct 2018 2:45 pm RNS SMC Approves The Use of Alkindi
8th Oct 2018 7:00 am RNS Headline Data for Chronocort European Phase III
5th Oct 2018 7:00 am RNS First patients enrolled in US Chronocort Phase III
20th Sep 2018 7:00 am RNS Results for the year ended 30 June 2018
15th Aug 2018 11:11 am RNS Update on Alkindi® in Germany
10th Jul 2018 1:36 pm RNS Director/PDMR Shareholding
21st Jun 2018 7:00 am RNS Notice of Results
18th Jun 2018 4:54 pm RNS Director/PDMR Shareholding
18th May 2018 3:33 pm RNS Director Dealings
18th May 2018 1:11 pm RNS Appointment of NOMAD and Joint Broker
15th May 2018 8:13 am RNS Launch of Alkindi for paediatric AI in Germany
11th May 2018 2:41 pm RNS Director Declaration
17th Apr 2018 3:58 pm RNS Holding(s) in Company
5th Apr 2018 2:08 pm RNS Director/PDMR Shareholding
5th Apr 2018 8:01 am RNS Director/PDMR Shareholding
3rd Apr 2018 2:39 pm RNS Result of GM and Completion of £10.5m Placing
21st Mar 2018 7:15 am RNS Hardman & Co: New capital funds commercial plans
20th Mar 2018 5:20 pm RNS Placing Update
14th Mar 2018 8:47 am RNS Proposed Placing
12th Mar 2018 7:00 am RNS Appointment of CRO to support US Chronocort trials
12th Mar 2018 7:00 am RNS Half-year Report
22nd Feb 2018 7:00 am RNS Diurnal announces grant of first patents in Japan
19th Feb 2018 7:00 am RNS Commercialisation agreement in Australia and NZ
13th Feb 2018 7:00 am RNS European marketing authorisation for Alkindi®
12th Feb 2018 7:00 am RNS Completion of patient enrolment in EU Phase III
9th Jan 2018 7:00 am RNS Positive results from Alkindi food matrix study
9th Jan 2018 7:00 am RNS Business Update and Notice of Interim Results
5th Jan 2018 5:06 pm RNS Issue of Equity
5th Jan 2018 5:04 pm RNS Replacement - Director Dealings
5th Jan 2018 1:19 pm RNS Director Dealings
19th Dec 2017 12:53 pm RNS Hardman Research: Alkindi®: On route to Europe
15th Dec 2017 12:50 pm RNS Diurnal receives positive CHMP opinion for Alkindi
15th Dec 2017 12:11 pm RNS CHMP positive opinion for Alkindi® (Infacort®)
8th Dec 2017 11:30 am RNS Total Voting Rights
29th Nov 2017 12:20 pm RNS Director/PDMR Shareholding
FTSE 100 Latest
Value8,809.74
Change53.53